Chen Yanqi, Wang Siyuan, Chen Xiaoyu, Wu Zhifang, He Fuming, Chen Qianming
Department of Pediatrics, Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Province Clinical Research Center for Oral Disease, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, China.
Department of Prosthodontics, Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Province Clinical Research Center for Oral Disease, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, China.
Bone Res. 2025 Sep 28;13(1):81. doi: 10.1038/s41413-025-00456-7.
Bone repair and regeneration is a complex spatiotemporal process recruiting a variety of cell types, which need to precisely mediated for effective healing post-damage. The concept of osteoimmunology emphasizes the extensive and intricate crosstalk between the bone and the immune system. Despite the significant advancements in understanding osteoimmunology, the precise role of dendritic cells (DCs) in this field remains under investigation. As key antigen-presenting cells, DCs are critical in orchestrating adaptive immune responses and maintaining tissue homeostasis. Recent researches have further revealed the potential of DCs to influence the development or acceleration of inflammatory and autoimmune bone disease, as well as their interaction with skeletal cells in the context of bone repair and regeneration. Therefore, an in-depth understanding of DCs in the osteoimmunology would be valuable. Herein, we discuss the effects of DCs on bone homeostasis and bone-related diseases (i.e., rheumatoid arthritis (RA), periodontitis, bone regeneration, and other bone abnormalities diseases), and introduce the innovative DCs-targeting biomaterials, aimed at promoting bone repair and regeneration. Furthermore, we summarize the underlying crosstalk between DCs and other cells (i.e., osteoclasts, mesenchymal stromal stem cells (MSCs), hematopoietic stem and progenitor cells (HSPCs), T and B cells) in the bone homeostasis and bone-related diseases. In conclusion, we propose that osteoimmunology offers a promising perspective for unraveling the mechanisms of bone-related diseases; meanwhile, targeting DCs from the perspective of osteoimmunology may provide innovative ideas and resolutions to achieve the internal homeostasis balance.
骨修复与再生是一个复杂的时空过程,需要多种细胞类型参与,损伤后需要精确调控才能有效愈合。骨免疫学概念强调骨骼与免疫系统之间广泛而复杂的相互作用。尽管在理解骨免疫学方面取得了重大进展,但树突状细胞(DCs)在该领域的确切作用仍在研究中。作为关键的抗原呈递细胞,DCs在协调适应性免疫反应和维持组织内稳态方面至关重要。最近的研究进一步揭示了DCs影响炎症性和自身免疫性骨病发展或加速的潜力,以及它们在骨修复和再生背景下与骨骼细胞的相互作用。因此,深入了解骨免疫学中的DCs将具有重要意义。在此,我们讨论DCs对骨稳态和骨相关疾病(即类风湿性关节炎(RA)、牙周炎、骨再生及其他骨异常疾病)的影响,并介绍创新的靶向DCs的生物材料,旨在促进骨修复和再生。此外,我们总结了DCs与其他细胞(即破骨细胞、间充质基质干细胞(MSCs)、造血干细胞和祖细胞(HSPCs)、T细胞和B细胞)在骨稳态和骨相关疾病中的潜在相互作用。总之,我们认为骨免疫学为阐明骨相关疾病的机制提供了一个有前景的视角;同时,从骨免疫学角度靶向DCs可能为实现体内稳态平衡提供创新思路和解决方案。